Belimumab

Details

Files
Generic Name:
Belimumab
Project Status:
Complete
Therapeutic Area:
Systemic lupus erythematosus
Manufacturer:
GlaxoSmithKline Inc.
Call for patient/clinician input open:
Brand Name:
Benlysta
Project Line:
Reimbursement Review
Project Number:
SR0251-000
Call for patient/clinician input closed:
NOC Status at Filing:
Post NOC
Submission Type:
Initial
Indications:
Systemic lupus erythematosus
Recommendation Type:
Do not list
Final Recommendation: